Dmitry Kaminskiy is the Managing Partner of Deep Knowledge Life Sciences. Mr. Kaminskiy is a trustee of the Biogerontology Research Foundation in Oxford and holds a BSc in Computer Science from the National University of Electronic Technology in Moscow. Prior to DKV, he served as an executive in the telecom and financial services industries.
Mr. Richards is the founding partner of York Bridge Capital, a private equity firm based in Toronto, Los Angeles, and Seoul. Mr. Richards has served as a C-level executive at the aerospace investment firm Girvan Technology Holdings, the biotech firm Epigenx Biosciences Inc., the advanced materials company Antaeus Energy Corporation, and was managing director of mining and metals for the Canadian Imperial Bank of Commerce. He holds two bachelors degrees in Biology and Accounting and Finance, as well as an MBA, all from Dalhousie University. Mr. Richards is also co-founder of Tech Coast Angels (TCA), the largest angel funding network in the United States.
Reid Dabney is a seasoned financial executive, investment banker and independent management consultant. He is a founding member/Managing Director of the CFO 911 financial consulting firm, an organization of senior executives that provides accounting, finance and operational expertise to both public and private companies.
His corporate experience includes serving as a controller, treasurer and chief financial officer for private companies and public multinationals. Mr. Dabney held the positions of European Treasurer for General Foods/Philip Morris, Director of Finance for the Pillsbury Company and Assistant Treasurer for Ecolab, Inc.
His Wall Street experience encompasses nearly 15 years as a senior equity research analyst and corporate finance professional with Keefe, Bruyette & Woods, RBC Capital Markets and the BMO Financial Group. During the course of his finance career, Mr. Dabney has raised in excess of $500 million of equity and more than $2.5 billion of debt for corporate clients.
He earned a BA from Claremont McKenna College and an MBA from the University of Pennsylvania’s Wharton School. Mr. Dabney has also served on the Alumni Board of Claremont McKenna College, as the Audit Committee Chair and as a member of the Compensation Committee for ChromaDex Corporation’s Board of Directors and as an advisor for multiple start-up operations.
Marco Demaria, PhD
Dr. Demaria is a group leader at the European Research Institute for the Biology of Aging (ERIBA/UMCG) in Groningen, Netherlands. He conducted his post-doctoral research in the laboratory of Judith Campisi at the Buck Institute for Research on Aging. Marco conducted his PhD at the University of Turin on transcriptional regulation of cancer metabolism. Dr. Demaria is also a consultant for Unity Biotechnology and an editor of Nature Scientific Reports.
John Schloendorn, PhD
John is CEO of Gene and Cell Technologies. He was formerly CEO of ImmunePath, Inc. He received his PhD from the Biodesign Institute of Arizona State University. He was the director of the Institute of Biomedical Gerontology for the Methuselah Foundation. John holds a BSc from the University of Tubingen.
Emil Kendziorra, MD
Dr. Emil Kendiorra is a medical doctor and entrepreneur. He was the founder of Medlanes GmbH and OnFeedback GmbH. He received his BS from Technische Universitat Darmstadt and his M.D. from the University of Goettingen Medical School where he conducted translational cancer research. When he is not busy building companies, he is active within the geroscience research and startup communities.
Alexander Perkins is a business development analyst with core expertise in financial modeling and operations. He has served as a venture capital consultant to startups in Silicon Valley and Los Angeles, and as a political strategist for several state and national campaigns. He completed his B.A and Master's degrees in Finance at Claremont McKenna College where he was a Robert Day Scholar. He is a classically trained pianist and serves on the board of the End of Life Companions nonprofit organization.
Franco Cortese is an associate at DKLS, helping to evaluate potential portfolio companies, advising on matters of general investment strategy and establishing strategic partnerships in the for-profit and non-profit life sciences sectors. Cortese is also the Deputy Director of the Biogerontology Research Foundation, a non-profit research foundation that executes research into the basic biology of ageing and the clinical translation of biogerontological interventions for ageing and age-related disease.